Back to mobile site

NeuroThera Labs acquires 54% stake in CliniQuantum for CAD$9.5 million

June 4, 2026 7:32 AM EDT Send to a Friend
SciSparc Ltd. (NASDAQ: SPRC) announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) completed the acquisition of approximately 54% of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login